MAHZI THERAPEUTICS ANNOUNCES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR MZ-1866 INVESTIGATIONAL THERAPY FOR PITT HOPKINS SYNDROME

Reuters · 2d ago

Please log in to view news